Status:
UNKNOWN
Regulation of Blood Dendritic Cells During Immune Therapy for Hymenoptera Venom Allergy
Lead Sponsor:
University of Rostock
Conditions:
Hymenoptera Venom Allergy
Eligibility:
All Genders
16-80 years
Phase:
NA
Brief Summary
Dendritic cells (DC) play a key role in the pathogenesis of allergic diseases. The regulation of blood dendritic cells in patients with hymenoptera venom allergy before and during immune therapy is un...
Eligibility Criteria
Inclusion
- Patients with diagnosed hymenoptera venom allergy
- No previous treatments for hymenoptera venom allergy
Exclusion
- Treatment with immunosuppressive agents
- Any malignant disease
- Infections within 1 week prior to the initiation of the treatment
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00947908
Start Date
June 1 2009
End Date
June 1 2010
Last Update
January 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rostock
Rostock, Mecklenburg-Vorpommern, Germany, 18057